Our cumulative meta-analysis indicated a distinct trend toward an apparent better respond rate for TT genotype of XPG rs2296147T>C polymorphism in cancer patients, which also showed the stable time-dependent trend (Figure 4). Here, ERCC5 is linked to cancer.